Amarin | Capitale Sociale E Riserve





Capitale Sociale E Riserve Cambiamento Data
AbbVie USD -3.27B 628M 2025-12
Alnylam Pharmaceuticals USD 789.18M 555.28M 2025-12
Amarin USD 458.89M 6.03M 2025-09
AstraZeneca USD 48.67B 2.78B 2025-12
BioCryst Pharmaceuticals USD -387.89M 33.7M 2025-09
DBV Technologies USD 52.85M 33.37M 2025-09
Esperion Therapeutics USD -451.36M 17.85M 2025-09
GlaxoSmithKline GBP 16.38B 229M 2025-12
Halozyme Therapeutics USD 48.81M 455.1M 2025-12
Heron Therapeutics USD 14.88M 42.14M 2025-09
Ionis Pharmaceuticals USD 617.97M 13.76M 2025-09
Nektar Therapeutics USD 85.09M 109.3M 2025-09
Neurocrine Biosciences USD 3.25B 249.5M 2025-12
Novartis USD 44.75B 2.7B 2025-09


Amarin Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.